TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
  • September 18, 2020

MISSISSAUGA, Canada—Eurofins, a pharmaceutical CDMO, completed a 14,500-square-foot GMP manufacturing facility in Mississauga, Canada, expanding its existing drug product operation capabilities. The facility includes fully equipped pre-formulation and formulation development laboratories, a development suite, multiple GMP manufacturing suites, clinical packaging, and warehousing. The addition supports the CDMO’s development and clinical manufacturing of oral solid dosage forms, including highly potent APIs.